FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035533043> ?p ?o ?g. }

• W3035533043 endingPage "474" @default.
• W3035533043 startingPage "465" @default.
• W3035533043 abstract "Background/objective: Observational clinical data from cladribine-treated patients with relapsing forms of multiple sclerosis (MS) were recorded in the Australian MS registry powered by the MSBase registry platform (5-year follow-up) and analysed to complement information from the pivotal cladribine clinical trials in MS. Methods: A cohort of 90 cladribine-treated patients with follow-up data reported by treating physicians and recorded in the Australian MSBase registry (database lock February 2016) were examined. Clinical data included Expanded Disability Status Scale (EDSS) scores, relapses and other disease-modifying drugs (DMDs) administered before and after cladribine treatment. Results: Mean age on starting cladribine was 47 years; mean age at MS onset was 34 years, and median baseline EDSS score was 5.25. Disability trajectories in patients with sufficient follow-up suggested an overall increasing trend prior to cladribine treatment which was reduced during the 2-year post-treatment. Approximately 80% of patients were EDSS progression-free, 65% remained relapse-free after 2 years and median time to next DMD was 1.7 years. Conclusion: These observational data suggest a disease-modifying effect in this cohort of relapsing MS patients characterised by older and more disabled patients. Since these data represent a single-arm cohort, clinical trials and larger comparative post-marketing studies are needed to validate and extend these findings." @default.
• W3035533043 created "2020-06-19" @default.
• W3035533043 creator A5006704248 @default.
• W3035533043 creator A5011859089 @default.
• W3035533043 creator A5014375641 @default.
• W3035533043 creator A5025814190 @default.
• W3035533043 creator A5027132248 @default.
• W3035533043 creator A5028230236 @default.
• W3035533043 creator A5030115168 @default.
• W3035533043 creator A5053813248 @default.
• W3035533043 creator A5055174813 @default.
• W3035533043 creator A5057675382 @default.
• W3035533043 creator A5060950347 @default.
• W3035533043 creator A5061404757 @default.
• W3035533043 creator A5070179323 @default.
• W3035533043 creator A5074955359 @default.
• W3035533043 creator A5080741844 @default.
• W3035533043 creator A5083946982 @default.
• W3035533043 date "2020-06-12" @default.
• W3035533043 modified "2023-10-17" @default.
• W3035533043 title "Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy" @default.
• W3035533043 cites W1971012221 @default.
• W3035533043 cites W1987053154 @default.
• W3035533043 cites W2104301864 @default.
• W3035533043 cites W2107424415 @default.
• W3035533043 cites W2122545833 @default.
• W3035533043 cites W2128361812 @default.
• W3035533043 cites W2139204856 @default.
• W3035533043 cites W2141222878 @default.
• W3035533043 cites W2146662840 @default.
• W3035533043 cites W2172431827 @default.
• W3035533043 cites W2415647615 @default.
• W3035533043 cites W2490444229 @default.
• W3035533043 cites W2512072495 @default.
• W3035533043 cites W2584413859 @default.
• W3035533043 cites W2751578374 @default.
• W3035533043 cites W2753716024 @default.
• W3035533043 cites W2761038804 @default.
• W3035533043 cites W2775223879 @default.
• W3035533043 cites W2790446387 @default.
• W3035533043 cites W2791760987 @default.
• W3035533043 cites W2801562584 @default.
• W3035533043 cites W2865333669 @default.
• W3035533043 cites W2869377759 @default.
• W3035533043 cites W2898629326 @default.
• W3035533043 cites W2900596677 @default.
• W3035533043 cites W2914053307 @default.
• W3035533043 cites W2926499529 @default.
• W3035533043 cites W2949139014 @default.
• W3035533043 doi "https://doi.org/10.1177/1352458520921087" @default.
• W3035533043 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7897790" @default.
• W3035533043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32530363" @default.
• W3035533043 hasPublicationYear "2020" @default.
• W3035533043 type Work @default.
• W3035533043 sameAs 3035533043 @default.
• W3035533043 citedByCount "23" @default.
• W3035533043 countsByYear W30355330432020 @default.
• W3035533043 countsByYear W30355330432021 @default.
• W3035533043 countsByYear W30355330432022 @default.
• W3035533043 countsByYear W30355330432023 @default.
• W3035533043 crossrefType "journal-article" @default.
• W3035533043 hasAuthorship W3035533043A5006704248 @default.
• W3035533043 hasAuthorship W3035533043A5011859089 @default.
• W3035533043 hasAuthorship W3035533043A5014375641 @default.
• W3035533043 hasAuthorship W3035533043A5025814190 @default.
• W3035533043 hasAuthorship W3035533043A5027132248 @default.
• W3035533043 hasAuthorship W3035533043A5028230236 @default.
• W3035533043 hasAuthorship W3035533043A5030115168 @default.
• W3035533043 hasAuthorship W3035533043A5053813248 @default.
• W3035533043 hasAuthorship W3035533043A5055174813 @default.
• W3035533043 hasAuthorship W3035533043A5057675382 @default.
• W3035533043 hasAuthorship W3035533043A5060950347 @default.
• W3035533043 hasAuthorship W3035533043A5061404757 @default.
• W3035533043 hasAuthorship W3035533043A5070179323 @default.
• W3035533043 hasAuthorship W3035533043A5074955359 @default.
• W3035533043 hasAuthorship W3035533043A5080741844 @default.
• W3035533043 hasAuthorship W3035533043A5083946982 @default.
• W3035533043 hasBestOaLocation W30355330431 @default.
• W3035533043 hasConcept C126322002 @default.
• W3035533043 hasConcept C1862650 @default.
• W3035533043 hasConcept C187212893 @default.
• W3035533043 hasConcept C201903717 @default.
• W3035533043 hasConcept C203014093 @default.
• W3035533043 hasConcept C23131810 @default.
• W3035533043 hasConcept C2779200787 @default.
• W3035533043 hasConcept C2780640218 @default.
• W3035533043 hasConcept C2780892749 @default.
• W3035533043 hasConcept C535046627 @default.
• W3035533043 hasConcept C71924100 @default.
• W3035533043 hasConcept C72563966 @default.
• W3035533043 hasConceptScore W3035533043C126322002 @default.
• W3035533043 hasConceptScore W3035533043C1862650 @default.
• W3035533043 hasConceptScore W3035533043C187212893 @default.
• W3035533043 hasConceptScore W3035533043C201903717 @default.
• W3035533043 hasConceptScore W3035533043C203014093 @default.
• W3035533043 hasConceptScore W3035533043C23131810 @default.
• W3035533043 hasConceptScore W3035533043C2779200787 @default.
• W3035533043 hasConceptScore W3035533043C2780640218 @default.

• next